Serum hyaluronate level correlates to the degree of liver fibrosis in pediatric liver diseases

Hepatology Research

Volumn 16, Issue 1, 1999, Pages 59-67

  Nakashima, Eisuke ^a   Kage, Masayoshi ^a   Fujisawa, Takuji ^a   Kato, Hirohisa ^a   Kojiro, Masamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Children; Computer image; Liver biopsy; Morphometry; Pathology; Serum marker

Indexed keywords

HYALURONIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INFANT; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032705423     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(99)00039-X     Document Type: Article

References (26)

1. Schaffer F., Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology. 44:1963;239-242.
2. Popper H., Udenfriend S. Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am. J. Med. 49:1970;707-721.
3. Ueno T., Inuzuka S., Torimura T. et al. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology. 105:1993;475-481.
4. Tamaki S., Ueno T., Torimura T., Sata M., Tanikawa K. Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. Gastroenterology. 111:1996;1049-1057.
5. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
6. Ichida F., Tsuji T., Omata M. et al. Classification report. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int. Hepatol. Com. 15:1992;1054-1059.
7. Yano M., Kumada H., Kage M. et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 23:1996;1334-1340.
8. Engström-Laurent A., Lööf L., Nyberg A., Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 5:1985;638-642.
9. Frébourg T., Delpech B., Bercoff E. et al. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology. 6:1986;392-395.
10. Nyberg A., Engström-Laurent A., Lööf L. Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology. 8:1988;142-146.
11. Gibson P.R., Fraser J.R.E., Brown T.J. et al. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology. 15:1992;1054-1059.
12. Ueno T., Inuzuka S., Torimura T. et al. Significance of serum type IV collagen levels in various liver diseases. Scand. J. Gastroenterol. 27:1992;513-520.
13. Parés A., Deulofeu R., Giménez A. et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and its usefulness as a marker of fibrosis. Hepatology. 24:1996;1399-1403.
14. Nakabayashi H., Takamatsu S., Tsuji H., Sakamoto S., Okamoto Y. Serum levels of hyaluronate in chronic liver diseases with special reference to hepatic fibrosis (in Japanese). Kanzo. 34:1993;452-456.
15. Ramadori G., Zöhrens G., Manns M. et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur. J. Clin. Invest. 21:1991;323-330.
16. Trivedi P., Cheeseman P., Portmann B., Hegarty J., Mowat A.P. Variation of serum type III procollagen peptide with age in healthy subjects and its comprehensive value in the assessment of disease activity in children and adults with chronic active hepatitis. Eur. J. Clin. Invest. 15:1985;69-74.
17. Trivedi P., Risteli J., Risteli L. et al. Serum type III procollagen and basement membrane proteins as non-invasive markers of hepatic pathology in Indian childhood cirrhosis. Hepatology. 7:1987;1249-1253.
18. Sasaki F., Hata Y., Hamada H., Takahashi H., Uchino J. Laminin and procollagen-III-peptide as a serum marker for hepatic fibrosis in congenital biliary atresia. J. Pediatr. Surg. 27:1992;700-703.
19. Trivedi P., Cheeseman P., Mowat A.P. Serum hyaluronic acid in healthy infants and children and its value as a marker of progressive hepatobiliary disease starting in infancy. Clin. Chim. Acta. 215:1993;29-39.
20. Jimenz W., Parés A., Caballería J. et al. Measurement of fibrosis in needle liver biopsies: evaluation of a colorimetric method. Hepatology. 5:1985;815-818.
21. Lindqvist U., Laurent T.C. Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand. J. Clin. Lab. Invest. 52:1992;613-621.
22. Davis B.H., Madri J.A. An immunohistochemical and serum ELISA study of type I and III collagen aminopropeptide in primary biliary cirrhosis. Am. J. Pathol. 128:1987;265-275.
23. Kage M., Fujisawa T., Shiraki K. et al. Pathology of chronic hepatitis C in children. Hepatology. 26:1997;771-775.
24. Kage M., Shimamatsu K., Nakashima E., Kojiro M., Inoue O., Yano M. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology. 25:1996;1028-1031.
25. Suzuki K., Endo R., Takikawa Y., Nakadate I., Sato S. Serum hyaluronate in patients with acute and fulminant hepatitis. J. Gastroenterol. 31:1996;237-241.
26. Gallorini A., Plebani M., Pontisso P. et al. Serum makers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon. Liver. 14:1994;257-264.